Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trialJ.P. Mohr, Alan J. Moskowitz, Jessica Overbey et al.|The Lancet|2013Cited by 1.2k
Apixaban versus no anticoagulation after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation in the Netherlands (APACHE-AF): a randomised, open-label, phase 2 trialFloris H.B.M. Schreuder, Catharina J.M. Klijn, Koen M. van Nieuwenhuizen et al.|The Lancet Neurology|2021Cited by 101
Apixaban versus Antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intraCerebral HaEmorrhage in patients with Atrial Fibrillation (APACHE-AF): study protocol for a randomised controlled trialCatharina J.M. Klijn, H. Bart van der Worp, Ale Algra et al.|Trials|2015Cited by 66